nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—Cardiogenic shock—Epirubicin—liver cancer	0.0336	0.0401	CcSEcCtD
Disopyramide—Cardiogenic shock—Doxorubicin—liver cancer	0.0311	0.0371	CcSEcCtD
Disopyramide—Haemoglobin decreased—Sorafenib—liver cancer	0.0277	0.033	CcSEcCtD
Disopyramide—Gynaecomastia—Sorafenib—liver cancer	0.017	0.0203	CcSEcCtD
Disopyramide—Cardiac failure congestive—Sorafenib—liver cancer	0.0152	0.0182	CcSEcCtD
Disopyramide—Cardiac failure—Sorafenib—liver cancer	0.0142	0.0169	CcSEcCtD
Disopyramide—Bundle branch block—Epirubicin—liver cancer	0.0139	0.0167	CcSEcCtD
Disopyramide—Bundle branch block—Doxorubicin—liver cancer	0.0129	0.0154	CcSEcCtD
Disopyramide—Abdominal pain upper—Sorafenib—liver cancer	0.0126	0.0151	CcSEcCtD
Disopyramide—Hypokalaemia—Sorafenib—liver cancer	0.0126	0.015	CcSEcCtD
Disopyramide—Neutropenia—Sorafenib—liver cancer	0.0112	0.0133	CcSEcCtD
Disopyramide—Erectile dysfunction—Sorafenib—liver cancer	0.011	0.0131	CcSEcCtD
Disopyramide—Feeling hot—Epirubicin—liver cancer	0.00897	0.0107	CcSEcCtD
Disopyramide—Arrhythmia—Sorafenib—liver cancer	0.00855	0.0102	CcSEcCtD
Disopyramide—Feeling hot—Doxorubicin—liver cancer	0.0083	0.00991	CcSEcCtD
Disopyramide—Dysgeusia—Sorafenib—liver cancer	0.00815	0.00974	CcSEcCtD
Disopyramide—Jaundice cholestatic—Epirubicin—liver cancer	0.00801	0.00956	CcSEcCtD
Disopyramide—Angioedema—Sorafenib—liver cancer	0.00761	0.00908	CcSEcCtD
Disopyramide—Syncope—Sorafenib—liver cancer	0.00747	0.00891	CcSEcCtD
Disopyramide—Jaundice cholestatic—Doxorubicin—liver cancer	0.00741	0.00885	CcSEcCtD
Disopyramide—Creatinine increased—Epirubicin—liver cancer	0.0074	0.00883	CcSEcCtD
Disopyramide—Loss of consciousness—Sorafenib—liver cancer	0.00732	0.00874	CcSEcCtD
Disopyramide—Atrioventricular block—Epirubicin—liver cancer	0.00726	0.00866	CcSEcCtD
Disopyramide—Ventricular tachycardia—Epirubicin—liver cancer	0.00704	0.0084	CcSEcCtD
Disopyramide—Dry mouth—Sorafenib—liver cancer	0.00693	0.00828	CcSEcCtD
Disopyramide—Creatinine increased—Doxorubicin—liver cancer	0.00684	0.00817	CcSEcCtD
Disopyramide—Atrioventricular block—Doxorubicin—liver cancer	0.00672	0.00802	CcSEcCtD
Disopyramide—Shock—Sorafenib—liver cancer	0.00669	0.00798	CcSEcCtD
Disopyramide—Thrombocytopenia—Sorafenib—liver cancer	0.00665	0.00794	CcSEcCtD
Disopyramide—Blood urea increased—Epirubicin—liver cancer	0.00665	0.00793	CcSEcCtD
Disopyramide—Skin disorder—Sorafenib—liver cancer	0.0066	0.00788	CcSEcCtD
Disopyramide—Ventricular tachycardia—Doxorubicin—liver cancer	0.00651	0.00778	CcSEcCtD
Disopyramide—Dry eye—Epirubicin—liver cancer	0.0065	0.00776	CcSEcCtD
Disopyramide—Anorexia—Sorafenib—liver cancer	0.00648	0.00773	CcSEcCtD
Disopyramide—Coma—Epirubicin—liver cancer	0.00643	0.00768	CcSEcCtD
Disopyramide—Blood urea increased—Doxorubicin—liver cancer	0.00615	0.00734	CcSEcCtD
Disopyramide—Dyspnoea—Sorafenib—liver cancer	0.00606	0.00723	CcSEcCtD
Disopyramide—Dry eye—Doxorubicin—liver cancer	0.00602	0.00718	CcSEcCtD
Disopyramide—Dyspepsia—Sorafenib—liver cancer	0.00598	0.00714	CcSEcCtD
Disopyramide—Coma—Doxorubicin—liver cancer	0.00595	0.00711	CcSEcCtD
Disopyramide—Decreased appetite—Sorafenib—liver cancer	0.00591	0.00705	CcSEcCtD
Disopyramide—Fatigue—Sorafenib—liver cancer	0.00586	0.00699	CcSEcCtD
Disopyramide—Constipation—Sorafenib—liver cancer	0.00581	0.00694	CcSEcCtD
Disopyramide—Pain—Sorafenib—liver cancer	0.00581	0.00694	CcSEcCtD
Disopyramide—Cardiac failure congestive—Epirubicin—liver cancer	0.00563	0.00673	CcSEcCtD
Disopyramide—Urticaria—Sorafenib—liver cancer	0.0054	0.00645	CcSEcCtD
Disopyramide—Body temperature increased—Sorafenib—liver cancer	0.00537	0.00641	CcSEcCtD
Disopyramide—Cardiac failure—Epirubicin—liver cancer	0.00524	0.00625	CcSEcCtD
Disopyramide—Hypoglycaemia—Epirubicin—liver cancer	0.00524	0.00625	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—liver cancer	0.00521	0.00622	CcSEcCtD
Disopyramide—Diplopia—Epirubicin—liver cancer	0.00511	0.0061	CcSEcCtD
Disopyramide—Asthenia—Sorafenib—liver cancer	0.00488	0.00582	CcSEcCtD
Disopyramide—Cardiac arrest—Epirubicin—liver cancer	0.00486	0.0058	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—liver cancer	0.00484	0.00578	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—liver cancer	0.00484	0.00578	CcSEcCtD
Disopyramide—Pruritus—Sorafenib—liver cancer	0.00481	0.00574	CcSEcCtD
Disopyramide—Blood creatinine increased—Epirubicin—liver cancer	0.00479	0.00572	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—liver cancer	0.00473	0.00564	CcSEcCtD
Disopyramide—Abdominal pain upper—Epirubicin—liver cancer	0.00467	0.00557	CcSEcCtD
Disopyramide—Hypokalaemia—Epirubicin—liver cancer	0.00465	0.00555	CcSEcCtD
Disopyramide—Diarrhoea—Sorafenib—liver cancer	0.00465	0.00555	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—liver cancer	0.00451	0.00538	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—liver cancer	0.0045	0.00537	CcSEcCtD
Disopyramide—Dizziness—Sorafenib—liver cancer	0.00449	0.00537	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—liver cancer	0.00445	0.00531	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—liver cancer	0.00443	0.00529	CcSEcCtD
Disopyramide—Vomiting—Sorafenib—liver cancer	0.00432	0.00516	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—liver cancer	0.00432	0.00516	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—liver cancer	0.0043	0.00514	CcSEcCtD
Disopyramide—Rash—Sorafenib—liver cancer	0.00429	0.00512	CcSEcCtD
Disopyramide—Dermatitis—Sorafenib—liver cancer	0.00428	0.00511	CcSEcCtD
Disopyramide—Headache—Sorafenib—liver cancer	0.00426	0.00508	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—liver cancer	0.00417	0.00498	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—liver cancer	0.00413	0.00493	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—liver cancer	0.00413	0.00493	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—liver cancer	0.00411	0.00491	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—liver cancer	0.00408	0.00487	CcSEcCtD
Disopyramide—Nausea—Sorafenib—liver cancer	0.00404	0.00482	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—liver cancer	0.00402	0.0048	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—liver cancer	0.00394	0.0047	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—liver cancer	0.00382	0.00456	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—liver cancer	0.00382	0.00456	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—liver cancer	0.00378	0.00451	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—liver cancer	0.00372	0.00444	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—liver cancer	0.00367	0.00439	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—liver cancer	0.00364	0.00435	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—liver cancer	0.0036	0.0043	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—liver cancer	0.00354	0.00422	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—liver cancer	0.00352	0.0042	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—liver cancer	0.0034	0.00406	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—liver cancer	0.00333	0.00398	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—liver cancer	0.00327	0.00391	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—liver cancer	0.00325	0.00389	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—liver cancer	0.00316	0.00377	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—liver cancer	0.00303	0.00362	CcSEcCtD
Disopyramide—Tension—Epirubicin—liver cancer	0.00302	0.00361	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—liver cancer	0.00301	0.0036	CcSEcCtD
Disopyramide—Nervousness—Epirubicin—liver cancer	0.00299	0.00357	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—liver cancer	0.00292	0.00349	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—liver cancer	0.0029	0.00346	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—liver cancer	0.00286	0.00341	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—liver cancer	0.00281	0.00335	CcSEcCtD
Disopyramide—Tension—Doxorubicin—liver cancer	0.00279	0.00334	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—liver cancer	0.00279	0.00333	CcSEcCtD
Disopyramide—Malaise—Epirubicin—liver cancer	0.00278	0.00331	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—liver cancer	0.00277	0.0033	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—liver cancer	0.00276	0.0033	CcSEcCtD
Disopyramide—Syncope—Epirubicin—liver cancer	0.00276	0.00329	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—liver cancer	0.0027	0.00323	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—liver cancer	0.00268	0.0032	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—liver cancer	0.00264	0.00315	CcSEcCtD
Disopyramide—Chest pain—Epirubicin—liver cancer	0.00262	0.00313	CcSEcCtD
Disopyramide—Discomfort—Epirubicin—liver cancer	0.00259	0.00309	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—liver cancer	0.00257	0.00307	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—liver cancer	0.00256	0.00306	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—liver cancer	0.00256	0.00305	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—liver cancer	0.00255	0.00305	CcSEcCtD
Disopyramide—Confusional state—Epirubicin—liver cancer	0.00253	0.00302	CcSEcCtD
Disopyramide—Oedema—Epirubicin—liver cancer	0.00251	0.003	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—liver cancer	0.0025	0.00299	CcSEcCtD
Disopyramide—Shock—Epirubicin—liver cancer	0.00247	0.00295	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—liver cancer	0.00246	0.00294	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—liver cancer	0.00244	0.00291	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—liver cancer	0.00243	0.0029	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—liver cancer	0.00242	0.00289	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—liver cancer	0.0024	0.00286	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—liver cancer	0.00239	0.00286	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—liver cancer	0.00237	0.00283	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—liver cancer	0.00235	0.0028	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—liver cancer	0.00234	0.0028	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—liver cancer	0.00232	0.00277	CcSEcCtD
Disopyramide—Shock—Doxorubicin—liver cancer	0.00229	0.00273	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—liver cancer	0.00228	0.00272	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—liver cancer	0.00227	0.00271	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—liver cancer	0.00226	0.00269	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—liver cancer	0.00226	0.00269	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—liver cancer	0.00225	0.00268	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—liver cancer	0.00224	0.00267	CcSEcCtD
Disopyramide—Somnolence—Epirubicin—liver cancer	0.00223	0.00267	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—liver cancer	0.00222	0.00264	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—liver cancer	0.00221	0.00264	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—liver cancer	0.00218	0.00261	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—liver cancer	0.00217	0.00259	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—liver cancer	0.00217	0.00259	CcSEcCtD
Disopyramide—Constipation—Epirubicin—liver cancer	0.00215	0.00256	CcSEcCtD
Disopyramide—Pain—Epirubicin—liver cancer	0.00215	0.00256	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—liver cancer	0.0021	0.00251	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—liver cancer	0.00209	0.00249	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—liver cancer	0.00207	0.00247	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—liver cancer	0.00207	0.00247	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—liver cancer	0.00207	0.00247	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—liver cancer	0.00205	0.00244	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—liver cancer	0.00202	0.00241	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—liver cancer	0.002	0.00239	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—liver cancer	0.002	0.00238	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—liver cancer	0.00199	0.00237	CcSEcCtD
Disopyramide—Pain—Doxorubicin—liver cancer	0.00199	0.00237	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—liver cancer	0.00199	0.00237	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—liver cancer	0.00192	0.00229	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—liver cancer	0.00185	0.0022	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—liver cancer	0.00184	0.00219	CcSEcCtD
Disopyramide—Asthenia—Epirubicin—liver cancer	0.0018	0.00215	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—liver cancer	0.00178	0.00212	CcSEcCtD
Disopyramide—Diarrhoea—Epirubicin—liver cancer	0.00172	0.00205	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—liver cancer	0.00167	0.00199	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—liver cancer	0.00166	0.00198	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—liver cancer	0.00164	0.00196	CcSEcCtD
Disopyramide—Vomiting—Epirubicin—liver cancer	0.0016	0.00191	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—liver cancer	0.00159	0.0019	CcSEcCtD
Disopyramide—Rash—Epirubicin—liver cancer	0.00158	0.00189	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—liver cancer	0.00158	0.00189	CcSEcCtD
Disopyramide—Headache—Epirubicin—liver cancer	0.00157	0.00188	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—liver cancer	0.00154	0.00183	CcSEcCtD
Disopyramide—Nausea—Epirubicin—liver cancer	0.00149	0.00178	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—liver cancer	0.00148	0.00176	CcSEcCtD
Disopyramide—Rash—Doxorubicin—liver cancer	0.00147	0.00175	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—liver cancer	0.00146	0.00175	CcSEcCtD
Disopyramide—Headache—Doxorubicin—liver cancer	0.00146	0.00174	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—liver cancer	0.00138	0.00165	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—AKT1—liver cancer	8.09e-05	0.000498	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	7.97e-05	0.000491	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYCS—liver cancer	7.91e-05	0.000487	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP2E1—liver cancer	7.81e-05	0.000481	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GOT1—liver cancer	7.76e-05	0.000478	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GGT1—liver cancer	7.76e-05	0.000478	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADAM17—liver cancer	7.61e-05	0.000469	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADAM17—liver cancer	7.59e-05	0.000468	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADAM17—liver cancer	7.52e-05	0.000463	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTP1—liver cancer	7.48e-05	0.000461	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—HMOX1—liver cancer	7.37e-05	0.000454	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYCS—liver cancer	7.3e-05	0.00045	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—F2—liver cancer	7.18e-05	0.000442	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GGT1—liver cancer	7.17e-05	0.000441	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GOT1—liver cancer	7.17e-05	0.000441	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PSMD10—liver cancer	7.16e-05	0.000441	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PSMA4—liver cancer	7.16e-05	0.000441	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—F2—liver cancer	7.15e-05	0.000441	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PSMA4—liver cancer	7.14e-05	0.00044	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PSMD10—liver cancer	7.14e-05	0.00044	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—F2—liver cancer	7.09e-05	0.000436	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PSMA4—liver cancer	7.07e-05	0.000435	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PSMD10—liver cancer	7.07e-05	0.000435	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTP1—liver cancer	6.97e-05	0.000429	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HMOX1—liver cancer	6.87e-05	0.000423	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTM1—liver cancer	6.87e-05	0.000423	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CG—liver cancer	6.87e-05	0.000423	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CG—liver cancer	6.85e-05	0.000422	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CG—liver cancer	6.78e-05	0.000418	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—F2—liver cancer	6.52e-05	0.000401	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP1A1—liver cancer	6.51e-05	0.000401	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—F2—liver cancer	6.5e-05	0.0004	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTP1—liver cancer	6.44e-05	0.000396	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—F2—liver cancer	6.43e-05	0.000396	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTM1—liver cancer	6.4e-05	0.000394	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HMOX1—liver cancer	6.35e-05	0.000391	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CG—liver cancer	6.24e-05	0.000384	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CG—liver cancer	6.22e-05	0.000383	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CG—liver cancer	6.16e-05	0.000379	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MTHFR—liver cancer	6.07e-05	0.000374	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP1A1—liver cancer	6.07e-05	0.000374	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CD—liver cancer	6.04e-05	0.000372	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CD—liver cancer	6.02e-05	0.000371	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	5.96e-05	0.000367	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARA—liver cancer	5.96e-05	0.000367	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTM1—liver cancer	5.92e-05	0.000364	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GLUL—liver cancer	5.81e-05	0.000358	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CPT1B—liver cancer	5.81e-05	0.000358	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MTHFR—liver cancer	5.66e-05	0.000349	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP1A1—liver cancer	5.61e-05	0.000345	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NR1H4—liver cancer	5.6e-05	0.000345	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARA—liver cancer	5.55e-05	0.000342	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKCE—liver cancer	5.55e-05	0.000342	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKCE—liver cancer	5.53e-05	0.000341	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTA3—liver cancer	5.51e-05	0.000339	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	5.48e-05	0.000338	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKCE—liver cancer	5.48e-05	0.000337	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CD—liver cancer	5.47e-05	0.000337	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	5.41e-05	0.000333	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	5.26e-05	0.000324	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF2—liver cancer	5.25e-05	0.000324	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	5.25e-05	0.000323	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF2—liver cancer	5.24e-05	0.000323	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MTHFR—liver cancer	5.23e-05	0.000322	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	5.2e-05	0.00032	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF2—liver cancer	5.19e-05	0.000319	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARA—liver cancer	5.13e-05	0.000316	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CG—liver cancer	5.1e-05	0.000314	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTA4—liver cancer	5.04e-05	0.00031	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—liver cancer	4.92e-05	0.000303	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTA2—liver cancer	4.91e-05	0.000302	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CSF2—liver cancer	4.91e-05	0.000302	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—RAF1—liver cancer	4.9e-05	0.000302	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CSF2—liver cancer	4.89e-05	0.000301	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—RAF1—liver cancer	4.88e-05	0.000301	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CSF2—liver cancer	4.84e-05	0.000298	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—H2AFX—liver cancer	4.84e-05	0.000298	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—IL2—liver cancer	4.83e-05	0.000298	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—RAF1—liver cancer	4.83e-05	0.000298	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—H2AFX—liver cancer	4.82e-05	0.000297	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—IL2—liver cancer	4.82e-05	0.000297	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	4.78e-05	0.000294	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—H2AFX—liver cancer	4.77e-05	0.000294	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—IL2—liver cancer	4.77e-05	0.000294	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	4.76e-05	0.000293	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CG—liver cancer	4.76e-05	0.000293	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTA1—liver cancer	4.74e-05	0.000292	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	4.72e-05	0.000291	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NAT2—liver cancer	4.68e-05	0.000288	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—liver cancer	4.59e-05	0.000283	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDOB—liver cancer	4.49e-05	0.000276	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CD—liver cancer	4.49e-05	0.000276	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—liver cancer	4.43e-05	0.000273	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CG—liver cancer	4.39e-05	0.000271	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL2—liver cancer	4.39e-05	0.00027	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL2—liver cancer	4.38e-05	0.000269	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TERT—liver cancer	4.37e-05	0.000269	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TERT—liver cancer	4.36e-05	0.000269	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL2—liver cancer	4.33e-05	0.000267	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TERT—liver cancer	4.32e-05	0.000266	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CRABP1—liver cancer	4.28e-05	0.000264	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—liver cancer	4.24e-05	0.000261	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CD—liver cancer	4.18e-05	0.000257	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—liver cancer	4.13e-05	0.000254	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KDR—liver cancer	4e-05	0.000246	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KDR—liver cancer	3.99e-05	0.000246	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK14—liver cancer	3.97e-05	0.000245	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK14—liver cancer	3.96e-05	0.000244	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KDR—liver cancer	3.95e-05	0.000243	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK14—liver cancer	3.92e-05	0.000242	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CB—liver cancer	3.91e-05	0.000241	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ESR1—liver cancer	3.9e-05	0.00024	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ESR1—liver cancer	3.89e-05	0.000239	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CD—liver cancer	3.86e-05	0.000238	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—F2—liver cancer	3.85e-05	0.000237	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ESR1—liver cancer	3.85e-05	0.000237	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—F2—liver cancer	3.84e-05	0.000236	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—liver cancer	3.81e-05	0.000235	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—F2—liver cancer	3.8e-05	0.000234	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HPGDS—liver cancer	3.74e-05	0.000231	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APC—liver cancer	3.68e-05	0.000227	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CG—liver cancer	3.68e-05	0.000227	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APC—liver cancer	3.67e-05	0.000226	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CG—liver cancer	3.67e-05	0.000226	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CB—liver cancer	3.64e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CG—liver cancer	3.64e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APC—liver cancer	3.64e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BRAF—liver cancer	3.46e-05	0.000213	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BRAF—liver cancer	3.45e-05	0.000213	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BRAF—liver cancer	3.42e-05	0.000211	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CB—liver cancer	3.37e-05	0.000207	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PSMD10—liver cancer	3.34e-05	0.000205	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PSMA4—liver cancer	3.34e-05	0.000205	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GOT2—liver cancer	3.25e-05	0.0002	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CD—liver cancer	3.24e-05	0.0002	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CD—liver cancer	3.23e-05	0.000199	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	3.21e-05	0.000198	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SERPINE1—liver cancer	3.2e-05	0.000197	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	3.2e-05	0.000197	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CD—liver cancer	3.2e-05	0.000197	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SERPINE1—liver cancer	3.19e-05	0.000197	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—KRAS—liver cancer	3.17e-05	0.000195	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	3.17e-05	0.000195	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SERPINE1—liver cancer	3.16e-05	0.000195	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—KRAS—liver cancer	3.16e-05	0.000195	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—KRAS—liver cancer	3.13e-05	0.000193	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2E1—liver cancer	3.05e-05	0.000188	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	2.91e-05	0.000179	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	2.9e-05	0.000179	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RAF1—liver cancer	2.89e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RAF1—liver cancer	2.88e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	2.88e-05	0.000177	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYCS—liver cancer	2.86e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RAF1—liver cancer	2.85e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CB—liver cancer	2.82e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MTOR—liver cancer	2.82e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MTOR—liver cancer	2.81e-05	0.000173	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CB—liver cancer	2.81e-05	0.000173	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GGT1—liver cancer	2.8e-05	0.000173	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GOT1—liver cancer	2.8e-05	0.000173	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MTOR—liver cancer	2.79e-05	0.000172	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CB—liver cancer	2.79e-05	0.000172	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HRAS—liver cancer	2.7e-05	0.000166	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HRAS—liver cancer	2.69e-05	0.000166	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HRAS—liver cancer	2.66e-05	0.000164	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN1B—liver cancer	2.65e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN1B—liver cancer	2.64e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—liver cancer	2.62e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN1B—liver cancer	2.62e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—liver cancer	2.61e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP3—liver cancer	2.6e-05	0.00016	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL2—liver cancer	2.59e-05	0.00016	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP3—liver cancer	2.59e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—liver cancer	2.59e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL2—liver cancer	2.58e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—liver cancer	2.58e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—liver cancer	2.57e-05	0.000158	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP3—liver cancer	2.56e-05	0.000158	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL2—liver cancer	2.56e-05	0.000158	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—liver cancer	2.55e-05	0.000157	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCND1—liver cancer	2.53e-05	0.000156	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JUN—liver cancer	2.52e-05	0.000155	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCND1—liver cancer	2.52e-05	0.000155	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTP1—liver cancer	2.52e-05	0.000155	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JUN—liver cancer	2.51e-05	0.000155	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CTNNB1—liver cancer	2.5e-05	0.000154	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCND1—liver cancer	2.5e-05	0.000154	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CTNNB1—liver cancer	2.5e-05	0.000154	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JUN—liver cancer	2.49e-05	0.000153	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—liver cancer	2.48e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CTNNB1—liver cancer	2.47e-05	0.000152	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—liver cancer	2.45e-05	0.000151	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—liver cancer	2.45e-05	0.000151	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN1A—liver cancer	2.45e-05	0.000151	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN1A—liver cancer	2.44e-05	0.00015	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—liver cancer	2.42e-05	0.000149	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN1A—liver cancer	2.41e-05	0.000149	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK8—liver cancer	2.39e-05	0.000147	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CA—liver cancer	2.38e-05	0.000147	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—liver cancer	2.38e-05	0.000147	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK8—liver cancer	2.38e-05	0.000147	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—liver cancer	2.37e-05	0.000146	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK8—liver cancer	2.36e-05	0.000145	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—liver cancer	2.35e-05	0.000145	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTM1—liver cancer	2.31e-05	0.000142	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CA—liver cancer	2.22e-05	0.000137	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—liver cancer	2.2e-05	0.000136	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—liver cancer	2.2e-05	0.000135	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP1A1—liver cancer	2.19e-05	0.000135	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STAT3—liver cancer	2.18e-05	0.000134	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—liver cancer	2.18e-05	0.000134	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STAT3—liver cancer	2.17e-05	0.000134	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STAT3—liver cancer	2.15e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CA—liver cancer	2.05e-05	0.000126	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTHFR—liver cancer	2.04e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—liver cancer	2.03e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFB1—liver cancer	2.02e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—liver cancer	2.02e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFB1—liver cancer	2.02e-05	0.000124	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARA—liver cancer	2.01e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—liver cancer	2e-05	0.000123	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFB1—liver cancer	2e-05	0.000123	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—liver cancer	1.95e-05	0.00012	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KRAS—liver cancer	1.87e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KRAS—liver cancer	1.87e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KRAS—liver cancer	1.85e-05	0.000114	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—liver cancer	1.81e-05	0.000112	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CA—liver cancer	1.72e-05	0.000106	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CG—liver cancer	1.72e-05	0.000106	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CA—liver cancer	1.72e-05	0.000106	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CA—liver cancer	1.7e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—liver cancer	1.68e-05	0.000103	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—liver cancer	1.67e-05	0.000103	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—liver cancer	1.66e-05	0.000102	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—liver cancer	1.66e-05	0.000102	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—liver cancer	1.64e-05	0.000101	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HRAS—liver cancer	1.59e-05	9.81e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HRAS—liver cancer	1.59e-05	9.78e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HRAS—liver cancer	1.57e-05	9.68e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—liver cancer	1.52e-05	9.39e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—liver cancer	1.52e-05	9.36e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CD—liver cancer	1.51e-05	9.3e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—liver cancer	1.5e-05	9.27e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—liver cancer	1.49e-05	9.18e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—liver cancer	1.41e-05	8.66e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—liver cancer	1.4e-05	8.63e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—liver cancer	1.39e-05	8.55e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CB—liver cancer	1.32e-05	8.1e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CA—liver cancer	8.02e-06	4.94e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—liver cancer	6.55e-06	4.04e-05	CbGpPWpGaD
